| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Dec―08 |
Information overload: How hot topics distract from news — COVID-19 spread in the USA |
Bin Yang, Ke-ke Shang, Michael Small, Naipeng Chao |
| 2 |
[GO] |
2022―Aug―19 |
Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual |
Ling Ni, Fang Ye, Qin Qiao, Yu Feng, Yazheng Yang, Hui Zhao, et al. (+9) Li-Nan Zhang, Meng-Li Cheng, Gengzhen Zhu, Xiaoli Li, Xuan Zhong, Ruifeng Li, Cheng-Feng Qin, Fang Chen, Chen Dong |
| 3 |
[GO] |
2022―Aug―19 |
One year of COVID-19 vaccination |
Meng-Li Cheng, Hui Zhao, Cheng-Feng Qin |
| 4 |
[GO] |
2022―Aug―19 |
Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives |
Yong Lin, Ailong Huang |
| 5 |
[GO] |
2022―Aug―19 |
Challenges of COVID-19 vaccination in patients with cancer |
Siyue Jia, Wenbo Zhu, Hudachuan Jiang, Fengcai Zhu |
| 6 |
[GO] |
2022―May―16 |
Policy and newly confirmed cases universally shape the human mobility during COVID-19 |
Kehan Li, Chao Li, Yinfeng Xiang, Fengxiang He, Shibo He, Jiming Chen, et al. (+2) Yi Fang, Youxian Sun |
| 7 |
[GO] |
2022―Apr―26 |
The evolving immunity to SARS-CoV-2 |
Chen Dong |
| 8 |
[GO] |
2022―Apr―24 |
Broadly neutralizing antibodies against SARS-CoV-2 variants |
Linqi Zhang |
| 9 |
[GO] |
2022―Apr―06 |
Cell-in-cell: an emerging player in COVID-19 and immune disorders |
Qiang Sun, Wei Chen |
| 10 |
[GO] |
2022―Feb―15 |
Policy and Newly Confirmed Cases Universally Shape the Human Mobility during COVID-19 |
Kehan Li, Chao Li, Yinfeng Xiang, Fengxiang He, Shibo He, Jiming Chen, et al. (+3) Yi Fang, Dacheng Tao, Youxian Sun |
| 11 |
[GO] |
2022―Jan―27 |
Cell-in-cell: an Emerging Player in COVID-19 and Immune Disorders |
Qiang Sun, Wei Chen |
| 12 |
[GO] |
2022―Jan―27 |
Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual |
Ling Ni, Fang Ye, Qin Qiao, Yu Feng, Yazheng Yang, Hui Zhao, et al. (+9) Li-nan Zhang, Meng-Li Cheng, Gengzhen Zhu, Xiaoli Li, Xuan Zhong, Ruifeng Li, Cheng-Feng Qin, Fang Chen, Chen Dong |
| 13 |
[GO] |
2022―Jan―27 |
One year of COVID-19 vaccination |
Meng-Li Cheng, Hui Zhao, Cheng-Feng Qin |
| 14 |
[GO] |
2022―Jan―27 |
Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives |
Yong Lin, Ailong Huang |
| 15 |
[GO] |
2022―Jan―27 |
Challenges of COVID-19 vaccination in patients with cancer |
Siyue Jia, Wenbo Zhu, Hudachuan Jiang, Fengcai Zhu |
|
